Skip to main content

Month: May 2021

WestBond Sets Quarterly Dividend Record and Payment Dates

DELTA, British Columbia, May 25, 2021 (GLOBE NEWSWIRE) — WestBond Enterprises Corporation (TSX-V: WBE) is pleased to announce that the quarterly dividend of $0.02 per share will be paid on June 21, 2021 to shareholders of record on June 7, 2021. The dividends are eligible dividends for the purposes of the Income Tax Act (Canada). Other information is available on the company’s website at www.westbond.ca and on SEDAR at www.sedar.com For further information please contact: Gennaro Magistrale Chief Executive Officer, President and DirectorWestBond Enterprises Corporation101 – 7403 Progress Way, Delta, B.C. V4G 1E7 Tel: (604) 940-3939 Cautionary Note Regarding Forward Looking Statements: This release includes certain statements and information that constitute forward-looking information within the meaning of applicable Canadian securities...

Continue reading

The Flowr Corporation Announces its BC Black Cherry wins the Highlife Cannabis Cup

TORONTO, May 25, 2021 (GLOBE NEWSWIRE) — The Flowr Corporation (TSX.V: FLWR; OTC: FLWPF) (“Flowr” or the “Company”) is pleased to announced that its latest strain, BC Black Cherry, won the top award at the Highlife Cannabis Cup. The Highlife Cannabis Cup, which was organized by Sessions Enterprises, host and creators of ‘The Highlife’, is the first of its kind in Canada and featured three micro-cultivators and three licensed producers. “We are really honoured to have been asked to participate and even more proud to have taken the top spot at the Highlife Cannabis Cup. This win against micro-growers and other premium producers illustrates our ability to grow high end cannabis,” commented Darryl Brooker, Chief Executive Officer of the Company. “Being able to garner accolades from top budtenders and cannabis connoisseurs is very important...

Continue reading

Osmotica Pharmaceuticals plc to Present at Jefferies Virtual Healthcare Conference 2021

BRIDGEWATER, N.J., May 25, 2021 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, announced today that Brian Markison, Chief Executive Officer, James “JD” Schaub, Chief Operating Officer, and Andrew Einhorn, Chief Financial Officer, will present at the Jefferies Virtual Healthcare Conference 2021 as follows:Date: Tuesday, June 1, 2021Time: 2:30 p.m. Eastern TimeWebcast: https://wsw.com/webcast/jeff174/osmt/1881765The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at www.osmotica.com under the “Investor & News” section. About Osmotica Pharmaceuticals plc Osmotica Pharmaceuticals plc (Nasdaq: OSMT) is a fully integrated biopharmaceutical company focused...

Continue reading

Knight to Present at the Jefferies 2021 Virtual Healthcare Conference

MONTREAL, May 25, 2021 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight”) a pan-America (ex-USA) specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Operating Officer, is scheduled to present at the Jefferies 2021 Virtual Healthcare Conference on Wednesday, June 2, 2021 at 10:30 AM ET. A live webcast of the event will be available at the following link: Event. A copy of the presentation will be available at www.gud-knight.com. About Knight Therapeutics Inc. Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing and commercializing innovative pharmaceutical products for Canada and Latin America. Knight owns Biotoscana Investments S.A., a pan-Latin American specialty pharmaceutical company....

Continue reading

Larimar Therapeutics Reports FDA Clinical Hold on CTI-1601 and Termination of Recently Announced Private Placement Financing

BALA CYNWYD, Pa., May 25, 2021 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for Friedreich’s ataxia (FA) and other complex rare diseases, today announced that the United States Food and Drug Administration (FDA) has placed a clinical hold on the CTI-1601 clinical program and that the company will not be closing a previously announced private placement financing. CTI-1601 is a recombinant fusion protein intended to deliver human frataxin into the mitochondria of patients with FA who are unable to produce enough of this essential protein. The clinical hold follows the previous notification by Larimar to the FDA of mortalities which occurred at the highest dose levels in an ongoing 180-day non-human primate (NHP) toxicology study,...

Continue reading

The Keg Royalties Income Fund Announces Trustee Election Results for its 2021 Unitholder Meeting

VANCOUVER, British Columbia, May 25, 2021 (GLOBE NEWSWIRE) — The Keg Royalties Income Fund (the “Fund”) (TSX: KEG.UN) is pleased to announce that all of the nominees listed in its information circular dated April 16, 2021 were elected as trustees of the Trust at its annual meeting of unitholders held on May 25, 2021 (the “Meeting”). The results of the voting for each nominee are as follows:NomineeVotes For Votes WithheldNo. % No. %Christopher Charles Woodward 7,954,550 95.09% 410,772 4.91%Tim Kerr 8,025,063 95.93% 340,258 4.07%In addition, the Fund reports that the appointment of KPMG LLP as the Fund’s auditors for the 2021 fiscal year was passed by a majority of the votes represented at the Meeting. About The Keg Royalties Income Fund The Fund is a limited purpose, open-ended trust established under the...

Continue reading

Horizon Bank to Acquire 14 TCF National Bank Branches in Michigan with $976 Million in Deposits and $278 Million in Loans

Extends Horizon’s Midwest retail franchise in 11 Michigan counties MICHIGAN CITY, Ind., May 25, 2021 (GLOBE NEWSWIRE) — Horizon Bank, a wholly owned subsidiary of Horizon Bancorp, Inc. (NASDAQ GS: HBNC) (“Horizon”), has entered into a definitive purchase and assumption agreement to acquire 14 TCF National Bank (“TCF”) branches in 11 Michigan counties with approximately $976 million in deposits and $278 million in associated loans, which are being divested by TCF Financial Corporation in connection with its merger with Huntington Bancshares Incorporated. “We are excited to welcome Horizon Bank’s newest employees and customers and introduce them to our record of exceptional service to consumers, small businesses, non-profits and municipalities across Michigan and Indiana,” Chairman and CEO Craig M. Dwight said. “This financially...

Continue reading

R1 RCM Announces Commencement of Secondary Offering by Selling Stockholders

CHICAGO, May 25, 2021 (GLOBE NEWSWIRE) — R1 RCM Inc. (“R1 RCM” or the “Company”) (NASDAQ: RCM) announced the commencement of an underwritten offering of an aggregate of 15,000,000 shares of its common stock by selling stockholders. The selling stockholders are TCP-ASC ACHI Series LLLP (“TCP-ASC”), a Delaware series limited liability limited partnership jointly owned by Ascension Health Alliance and investment funds affiliated with TowerBrook Capital Partners, L.P., and Joseph Flanagan, the President and Chief Executive Officer of the Company. The underwriters will have a 30-day option to purchase up to an additional 2,250,000 shares of common stock from TCP-ASC. R1 RCM is not selling any shares in the offering and will not receive any of the proceeds from the sale of common stock by the selling stockholders. Barclays, J.P. Morgan,...

Continue reading

TFF Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference

AUSTIN, Texas, May 25, 2021 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that management will present a corporate overview at the Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021 at 11:30am EST. To register in advance for the corporate presentation, sign up here. Replay Link: A replay will be accessible on the Events & Presentations page of the Investors section on the Company’s website at https://ir.tffpharma.com/events-and-presentations/events About TFF Pharmaceuticals TFF Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products...

Continue reading

AMC Networks Inc. Announces Change to Location and Format of 2021 Annual Meeting of Stockholders

NEW YORK, May 25, 2021 (GLOBE NEWSWIRE) — AMC Networks Inc. (“AMC Networks” or the “Company”) (Nasdaq:AMCX) today announced that it will be holding its Annual Meeting of Stockholders (the “Annual Meeting”) in person at the J.P. Morgan Club at the Madison Square Garden Arena, located on Seventh Avenue between West 31st Street and West 33rd Street, New York, New York 10001. As previously announced, the meeting will be held on Wednesday, June 16, 2021 at 10:00 a.m. Eastern Daylight Time. Stockholders will not be able to attend the Annual Meeting virtually. There is no change to the items of business to be addressed at the Annual Meeting, which are described in the proxy materials previously made available to the Company’s stockholders. As described in those proxy materials, the Board of Directors fixed the close of business on April...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.